Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/25/2010US20100297769 Centromere sequences and minichromosomes
11/25/2010US20100297768 Nanofibrillar structure and applications including cell and tissue culture
11/25/2010US20100297767 Novel cell culture and methods of producing and collecting cell masses using the same
11/25/2010US20100297766 Method of Removing Undesired Tissue from Connective Tissue
11/25/2010US20100297765 Method for producing langerhans cells or interstitial dendritic cells or both from cd14+ monocytes
11/25/2010US20100297764 Use of a hydrogel for the culture of chondrocytes
11/25/2010US20100297763 Conditionally immortalized long-term stem cells and methods of making and using such cells
11/25/2010US20100297762 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
11/25/2010US20100297761 Novel Use of Liver X Receptor Agonists
11/25/2010US20100297760 Pharmaceutical composition and a method for treatment of prostate cancer
11/25/2010US20100297759 System and process for sorting biological particles in liquid flow
11/25/2010US20100297758 Artificial peptide and use thereof
11/25/2010US20100297757 Renal progenitor cells from embryonic stem cells
11/25/2010US20100297756 Means for delivery of nucleic acids active for gene silencing using synthetic polymers
11/25/2010US20100297755 Method for Differentiating of Human Embryonic Stem Cells Into the Osteoblastic Lineage
11/25/2010US20100297754 Device for carrying out cell lysis and nucleic acid extraction
11/25/2010US20100297753 Transfection by laser poration on rotating cylinder
11/25/2010US20100297733 Systems And Methods For The Capture And Separation Of Microparticles
11/25/2010US20100297722 Transgenic moss producing terpenoids
11/25/2010US20100297702 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/25/2010US20100297700 Antibodies to TNF Alpha
11/25/2010US20100297699 Nucleic Acids Encoding Humanized Immunoglobulin That Binds Alpha4Beta7 Integrin
11/25/2010US20100297697 Methods for increasing protein titers
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297693 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
11/25/2010US20100297689 Placental stem cell populations
11/25/2010US20100297685 Methods for culturing and analyzing cells
11/25/2010US20100297675 Substrate and method for culturing breast cells
11/25/2010US20100297674 NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
11/25/2010US20100297665 Method for testing and screening p38 map kinase modifiers
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297662 Antibody and use thereof
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297613 Nucleic acid, amino acid encoded by said nucleic acid, probe comprising said nucleic acid or said amino acid, and screening method using said probe
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297254 Nutraceutical composition and methods of use
11/25/2010US20100297253 Treatment of diabetes with milk protein hydrolysate
11/25/2010US20100297246 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb
11/25/2010US20100297234 Method of using an extracellular matrix to enhance cell transplant survival and differentiation
11/25/2010US20100297233 Oscillating cell culture bioreactor
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297212 Scaffold for cell growth and differentiation
11/25/2010US20100297208 Scaffold
11/25/2010US20100297189 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
11/25/2010US20100297178 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/25/2010US20100297175 Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
11/25/2010US20100297174 Influenza virus vaccines and uses thereof
11/25/2010US20100297160 High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens
11/25/2010US20100297153 Binding molecules for treatment and detection of cancer
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/25/2010US20100297151 Antibodies against human il-21 receptor and uses therefor
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297147 Compositions and methods for modulating tlr14 activity
11/25/2010US20100297146 Immune system programming through b7-dc
11/25/2010US20100297145 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
11/25/2010US20100297138 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297130 Protective anti-glucan antibodies with preference for beta-1,3-glucans
11/25/2010US20100297124 Induced internalization of surface receptors
11/25/2010US20100297123 Combination therapy to inhibit t cell effector function
11/25/2010US20100297121 Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
11/25/2010US20100297119 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/25/2010US20100297114 Antigen presenting cell targeted vaccines
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297108 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
11/25/2010US20100297103 Antibody having enhanced adcc activity and method for production thereof
11/25/2010US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides
11/25/2010US20100297093 Modified t cell receptors and related materials and methods
11/25/2010US20100297091 Compositions and methods for treatment of melanomas
11/25/2010US20100297090 Hematopoietic cell culture nutrient supplement
11/25/2010US20100297089 Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
11/25/2010US20100297088 Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof
11/25/2010US20100297087 Pluripotent stem cells characterized by expression of germline specific genes
11/25/2010US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same
11/25/2010US20100297076 Targeted interferon demonstrates potent apoptotic and anti-tumor activities
11/25/2010US20100297070 COMPOSITIONS AND METHODS FOR AMELIORATING CNS INFLAMMATION, PSYCHOSIS, DELIRIUM, PTSD or PTSS
11/25/2010US20100297061 Stat3 antagonists and their uses as vaccines against cancer
11/25/2010US20100297024 Promoter inducible by reactive oxygen species and vector comprising the same
11/25/2010US20100297023 Lipid
11/25/2010US20100297022 Magnetosome Gene Expression in Eukaryotic Cells
11/25/2010US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors
11/25/2010US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/25/2010DE102009022772A1 Mikroorganismus zur Expression eines humanen Membranproteins Microorganism for expression of a human membrane protein
11/25/2010DE102008050424B4 Verfahren und Vorrichtung zur homogenen Verteilung einer zellulären Suspension in porösem Trägermaterial für die Herstellung von vitalem biologischem Ersatzgewebe Method and device for the homogeneous distribution of a cellular suspension in the porous support material for the production of vital biological replacement tissue
11/25/2010CA2762853A1 Cell therapy for brain tissue damage
11/25/2010CA2762679A1 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways
11/25/2010CA2762362A1 Synthetic graft
11/24/2010EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/24/2010EP2253708A1 Suppresion of specific classes of soybean seed protein genes
11/24/2010EP2253704A1 Oligonucleotide mediated nucleic acid recombination
11/24/2010EP2253703A1 Human coagulation factor VII variants
11/24/2010EP2253700A1 A method for producing test systems from donors suffering from adverse effects of medicaments and /or medical treatments, and uses of said systems
11/24/2010EP2253699A1 Dry powder cell culture products containing lipid and methods of production thereof
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR
11/24/2010EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof
11/24/2010EP2252688A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 1827